Daejeon, South Korea

Yonggil Kim



 

Average Co-Inventor Count = 8.8

ph-index = 1


Location History:

  • Daejon, KR (2011)
  • Daejeon, KR (2011 - 2014)

Company Filing History:


Years Active: 2011-2014

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yonggil Kim: Innovator in Pharmaceutical Chemistry

Introduction

Yonggil Kim is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel piperazine compounds. With a total of 3 patents to his name, Kim's work focuses on innovative solutions for mental health treatment.

Latest Patents

One of Yonggil Kim's latest patents involves phenyl piperazine compounds and their pharmaceutical compositions. This invention relates to novel piperazine derivatives or pharmaceutically acceptable salts, which exhibit high binding affinity for the Serotonin 1A (5-HT1A) receptor. The pharmaceutical composition developed by Kim is aimed at the treatment and prevention of depression and anxiety. It includes an effective amount of the piperazine compound and outlines a method for treating conditions related to the 5-HT1A receptor in mammals.

Career Highlights

Throughout his career, Yonggil Kim has worked with notable companies such as SK Holdings Co., Ltd. and SK Biopharmaceuticals Co., Ltd. His experience in these organizations has allowed him to contribute to significant advancements in pharmaceutical research and development.

Collaborations

Yonggil Kim has collaborated with several professionals in his field, including Nahmryune Cho and Yunhee Kim. These collaborations have further enhanced his research and innovation efforts.

Conclusion

Yonggil Kim stands out as an influential inventor in the pharmaceutical industry, with a focus on developing innovative treatments for mental health conditions. His contributions continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…